High systolic blood pressure-attributable chronic kidney disease mortality among young adults increased globally by an estimated annual percentage change of 1.75% from 1990 to 2021.
Observational
Does high systolic blood pressure increase the mortality and DALY burden of chronic kidney disease in young adults aged 25-49 years?
The global mortality and disability burden of chronic kidney disease attributable to high systolic blood pressure in young adults has increased substantially over the past three decades, emphasizing the urgent need for early hypertension management.
Effect estimate: EAPC 1.75% (95% CI 1.69-1.81)
Absolute Event Rate: 0.55% vs 0.32%
The burden of CKD attributable to high SBP among young adults has increased substantially over the past three decades and is projected to rise further, reflecting persistent global inequalities. These findings highlight the urgent need for strengthened and targeted strategies for hypertension prevention and management in younger populations worldwide.
He et al. (Thu,) conducted a observational in Chronic kidney disease attributable to high systolic blood pressure. High systolic blood pressure vs. Theoretical minimum risk exposure level (110-115 mmHg) was evaluated on Mortality rate attributable to high SBP (per 100,000 population) (EAPC 1.75%, 95% CI 1.69-1.81). High systolic blood pressure-attributable chronic kidney disease mortality among young adults increased globally by an estimated annual percentage change of 1.75% from 1990 to 2021.